555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [thống kê xsmb hôm nay]
12 de mar. de 2024 · Overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) has improved in clinical trials over the last 20 years. 1, 2 It is unclear whether new …
De novo metastatic hormone-sensitive prostate cancer usually has a dismal prognosis, which has slightly improved in recent years thanks to the introduction of new hormonal agents and …
21 de mar. de 2023 · ADT–docetaxel–abiraterone–prednisone is recommended as first-line treatment for fit men with de novo metastatic hormone-sensitive prostate cancer (mHSPC), …
9 de set. de 2024 · Prostate cancer treatments paradigms are in continuous evolution, especially in the metastatic setting. In this context, the Genito-Urinary Group of Italian Association of …
21 de jun. de 2023 · In patients with metastatic hormone-sensitive prostate cancer, randomized trials have demonstrated overall survival improvement with triplet therapy of androgen-receptor …
Bài viết được đề xuất: